BCTG Acquisition Corp.

Merged
CIK: 1819133•Ticker: BCTG•Merged Ticker: TNGX
Successfully merged with Tango Therapeutics, Inc. • Now trading as TNGX

SPAC Overview

$167M
IPO Size
$167M
Trust (as of 2021-06-30)
Completed
Current Status
2020
IPO Year

Timeline Progress

About

BCTG Acquisition Corp. is a blank-check company seeking to complete a merger or other business combination with an unidentified business. It intends to focus on innovative biotechnology companies in North America and Europe.

Investment Focus

Biopharmaceuticals

Geographic Focus

North America, Europe

Embarc dashboard

What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.

  • Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
  • Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
  • The full 8-K lifecycle timeline, each event linked to its filing
  • Price history across the unit, share and warrant tickers
  • Follow it, and see it change on your watchlist
Open in the dashboard

Stock Performance

TNGX
Trading Symbol
First Trade
September 4, 2020
$10.33
At Merger
August 12, 2021
$9.56
-7%
6 Months Post-Merger
February 10, 2022
$9.38
-2%
1 Year Post-Merger
August 12, 2022
$5.22
-45%
2 Years Post-Merger
August 11, 2023
$7.51
-21%
Current Price
October 1, 2026
$24.45
+137%

Key Information

IPO Date
September 4, 2020
Total Redemptions
$11.1M
PIPE
$186M
State of Incorporation
DE
SIC
6770
Completion Date
August 10, 2021
Merger Target
Tango Therapeutics, Inc.
SPAC Ticker
BCTG
Merged Ticker
TNGX